Evidence map›Paper›PMID 35601105›Full record

SynthesisFrontiers in cellular and infection microbiology2022

Effect of

Yang Guo, Xue-Shan Cao, Guan-Yi Guo, Meng-Ge Zhou, Bo Yu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. The Potential Role ofMicroorganisms · 2025
    Review
  8. Review
  9. The influence ofComputational and structural biotechnology journal · 2024
    Review
  10. Review
  11. Review
  12. Antibiotics (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Exploring the Link betweenAntibiotics (Basel, Switzerland) · 2024
    Review
  15. Change in Diagnosis ofAntibiotics (Basel, Switzerland) · 2024
    Review
  16. Article
  17. Review
  18. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Review
  19. Gastric microbiota dysbiosis andFrontiers in microbiology · 2023
    Review
  20. Influence ofWorld journal of clinical oncology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Yang GuoDepartment of Dermatology, Institute of Dermatology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
Xue-Shan CaoCollege of Life Science and Oceanography, Shenzhen University, Shenzhen, China.
Guan-Yi GuoDepartment of Hematology, the Second Hospital of Hebei Medical University, Key Laboratory of Hematology, Shijiazhuang, China.
Meng-Ge ZhouVanke School of Public Health, Tsinghua University, Beijing, China.
Bo YuDepartment of Dermatology, Institute of Dermatology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
University of Hong Kong - Shenzhen Hospital · CNHebei Medical University · CNShenzhen University · CNVanke (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We did a systematic search based on three databases (PubMed, EMBASE, and Web of Science) in November 2021. Additional articles were also identified by reviewing references cited in the included papers. Human studies that reported changes in gastric microbiota following successful Results: In total, nine studies enrolling 546 participants were included. Regarding quadruple therapy, alpha diversity indexes increased within 1 month after eradication; significant differences in gastric microbial community structure between before and after eradication were also seen within 1 month. The trends of the above-mentioned diversity changes persisted with a follow-up of 6 months. The microbial composition altered significantly after eradication and the relative abundance of Conclusion: In conclusion, successful

Indexed as

Gastrointestinal MicrobiomeHelicobacter InfectionsHelicobacter pyloriMicrobiotaStomach NeoplasmsAnti-Bacterial AgentsDysbiosisHumansAnti-Bacterial Agentseradicationgastric microbiotaHelicobacter pylorihumansmeta-analysis

Identifiers

PMID35601105
PMCPMC9114356
OpenAlexW4225368659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.